SLC5A2 and chronic obstructive pulmonary disease: Furthermore, while the smoking status is not routinely recorded in CGRD, those demographics (e.g., age and sex) and medical disorders (e.g., COPD) associated with smoking behaviors were similar for the two SGLT2 inhibitor groups [60].